Evaluate the Efficacy and Safety of HL151 Versus Talion Tab. in Pruritus Cutaneus
Status:
Completed
Trial end date:
2018-01-30
Target enrollment:
Participant gender:
Summary
a Multicenter, Randomized, Double-blinded, Active-controlled, Parallel, Phase Ⅲ Study to
Evaluate the Efficacy and Safety of HL151 versus Talion Tab. in Pruritus cutaneus.
- Endpoint: VAS Score Change, Investigator's assessment of overall treatment